Given that the above-mentioned clinical data point to a key role for IL-6 elevation in the pathogenesis of QTc prolongation associated with severe COVID-19, we conducted additional experiments in animal and cell models to further substantiate the individual significant impact of IL-6 in the phenomenon. The gene discussed is IL6; the disease is COVID-19.